1 – 10 of 232
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
(2026) In The journal of prevention of Alzheimer's disease
- Contribution to journal › Article
- 2025
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum
- Contribution to journal › Article
-
Mark
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum
- Contribution to journal › Article
-
Mark
Personalised regional modelling predicts tau progression in the human brain
- Contribution to journal › Article
-
Mark
Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease
- Contribution to journal › Article
-
Mark
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
- Contribution to journal › Article
-
Mark
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
(2025) In EMBO Molecular Medicine
- Contribution to journal › Article
-
Mark
Clinical Performance of the Elecsys CSF pTau181/Aβ42 Ratio for Concordance with Tau-PET in Two Independent Cohorts
- Contribution to journal › Article
-
Mark
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias : An international multi-center study
- Contribution to journal › Article
